INS and type 2 diabetes mellitus: Chronic activation of pro-inflammatory pathways in insulin target tissues (liver, muscle, adipose tissue and pancreatic islets), under the joint regulation of environmental factors and genetics combined with a variety of epigenetic modifications could contribute to T2D development [124] that is a typical metabolic inflammatory disease [125].